Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishment of Noninvasive Diagnosis Model for High-risk Varices in Cirrhosis Patients Based on iLivTouch

NCT06392503 is registered in ClinicalTrials.gov with Beijing 302 Hospital as lead sponsor.

NCT NCT06392503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06392503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishment of Noninvasive Diagnosis Model for High-risk Varices in Cirrhosis Patients Based on iLivTouch
Lead sponsor
Beijing 302 Hospital
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2023
Completion date
December 31, 2025
Enrollment
2,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cirrhosis, varices